AME
75
3
CA
21
-9
TGT
50
-7
PCAR
56
4
XOM
50
5
TROW
62
6
A
51
8
HON
68
-2
UA
36
3
STZ
48
6
MTB
75
2
CHRW
79
-3
AON
65
3
FCX
75
3
ESS
47
7
NWS
62
2
ETR
49
2
LEN
21
-9
CNP
52
3
TMO
62
2
AME
75
3
CA
21
-9
TGT
50
-7
PCAR
56
4
XOM
50
5
TROW
62
6
A
51
8
HON
68
-2
UA
36
3
STZ
48
6
MTB
75
2
CHRW
79
-3
AON
65
3
FCX
75
3
ESS
47
7
NWS
62
2
ETR
49
2
LEN
21
-9
CNP
52
3
TMO
62
2
Financhill
Back

Adaptive Hedged Multi-AssetETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
41

AMAX
Adaptive Hedged Multi-AssetETF

Last Price:
$8.03
Seasonality Move:
0.15%
Sell
41

MNPR
Monopar Therapeutics, Inc.

Last Price:
$70.95
Seasonality Move:
25.93%
Sell
41
Adaptive Hedged Multi-AssetETF (AMAX) is a Sell

Is Adaptive Hedged Multi-AssetETF a Buy, Sell or Hold?

  • The current Adaptive Hedged Multi-AssetETF [AMAX] share price is $8.08. The Score for AMAX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • AMAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $70.92. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AMAX Stock Price Chart

What is Adaptive Hedged Multi-AssetETF's stock price today?

  • The Adaptive Hedged Multi-AssetETF share price today is $8.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMAX is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $70.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

AMAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 53.95 Buy
Chaikin Money Flow: -8409 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.96 - 8.06) Buy
Bollinger Bands (100): (7.95 - 8.23) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.54 Sell
Relative Strength Index (14 RSI): 41.3 Sell
Chaikin Money Flow: 7856 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.72 - 85.64) Sell
Bollinger Bands (100): (46.03 - 89.35) Buy

AMAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.01 Buy
20-day SMA: 8.02 Buy
50-day SMA: 8.11 Sell
200-day SMA: 7.9 Buy
8-day EMA: 8.02 Buy
20-day EMA: 8.03 Buy
50-day EMA: 8.07 Buy
200-day EMA: 7.99 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.44 Sell
20-day SMA: 77.62 Sell
50-day SMA: 81.13 Sell
200-day SMA: 52.54 Buy
8-day EMA: 71.33 Sell
20-day EMA: 75.43 Sell
50-day EMA: 76.56 Sell
200-day EMA: 56.82 Buy

Adaptive Hedged Multi-AssetETF Earnings Growth & AMAX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Adaptive Hedged Multi-AssetETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):